MedTrace Logo

Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis

NCT02029066 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2015-08-13

No results posted yet for this study

Summary

This study is designed to evaluate the pharmacokinetics of solamargine of SR-T100 gel. As safety parameters, adverse events, and vital signs (blood pressure, heart rate, and body temperature) will be recorded.

Conditions

  • Actinic Keratosis

Interventions

DRUG

SR-T100 gel

2g of SR-T100 will topical apply on 100 cm\^2 once for 24 hours.

Sponsors & Collaborators

  • G&E Herbal Biotechnology Co., LTD

    lead INDUSTRY

Principal Investigators

  • Hamm-Ming Sheu, M.D. · National Cheng-Kung University Hospital

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02029066 on ClinicalTrials.gov